ArticleDermatology and therapy2024

A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis.

Andrew F Alexis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.